Should prostate-specific antigen screening be offered to asymptomatic men?
about
PSA-based prostate cancer screening: the role of active surveillance and informed and shared decision making.Novel therapeutic strategies for metastatic prostate cancer in the post-docetaxel settingEvaluation of prostate cancer prevalence in Iranian male population with increased PSA level, a one center experience.Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study.
P2860
Should prostate-specific antigen screening be offered to asymptomatic men?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Should prostate-specific antigen screening be offered to asymptomatic men?
@en
Should prostate-specific antigen screening be offered to asymptomatic men?
@nl
type
label
Should prostate-specific antigen screening be offered to asymptomatic men?
@en
Should prostate-specific antigen screening be offered to asymptomatic men?
@nl
prefLabel
Should prostate-specific antigen screening be offered to asymptomatic men?
@en
Should prostate-specific antigen screening be offered to asymptomatic men?
@nl
P2860
P356
P1476
Should prostate-specific antigen screening be offered to asymptomatic men?
@en
P2093
Chris H Bangma
Heidi A van Vugt
P2860
P304
P356
10.1586/ERA.10.64
P577
2010-07-01T00:00:00Z